Page 29 - U.S. Growth Stocks

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

UPDATED Apr 11, 2026

Discover U.S. Growth Stocks that are on the NYSE and NASDAQ. Sorted by forecasted growth, these stocks have higher than expected earnings or sales growth compared to other companies.

5,146 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
CLGN	US$0.38	-27.8%	-84.3%	US$5.5m	n/a	2.3	60.1%	n/a	Pharmaceuticals & Biotech
TNYA	US$0.69	-0.7%	40.0%	US$149.7m	US$9.00	1.2	60.1%	n/a	Pharmaceuticals & Biotech
BRCC	US$0.81	1.1%	-62.5%	US$201.7m	US$2.50	2.1	60.1%	n/a	Food, Beverage & Tobacco
RZLV	US$2.38	-23.5%	108.8%	US$949.2m	US$10.75	20.3	60.0%	n/a	Software
IONS	US$75.17	0.5%	169.4%	US$12.4b	US$97.60	13.2	59.9%	n/a	Pharmaceuticals & Biotech
VERA	US$45.04	10.2%	100.8%	US$3.2b	US$79.00	5.3	59.9%	n/a	Pharmaceuticals & Biotech
CDXS	US$2.24	23.1%	-4.7%	US$203.5m	US$6.58	2.9	59.9%	n/a	Pharmaceuticals & Biotech
BRCB	US$14.14	7.3%	n/a	US$707.8m	US$24.57	1.2	59.9%	n/a	Consumer Services
HGTY	US$11.12	1.4%	28.1%	US$3.8b	US$13.29	29.1	59.8%	n/a	Insurance
NAT	US$5.72	-7.0%	126.1%	US$1.2b	US$6.25	98.7	59.8%	8.2%	Energy
SKYX	US$1.12	-2.6%	15.8%	US$149.3m	US$4.18	1.6	59.7%	n/a	Capital Goods
CMPX	US$5.17	-5.1%	205.0%	US$931.1m	US$13.64	4.7	59.7%	n/a	Pharmaceuticals & Biotech
IVF	US$2.01	-19.9%	-99.2%	US$3.2m	US$20.00	-0.3	59.7%	n/a	Healthcare
NAMS	US$34.76	5.4%	129.9%	US$4.0b	US$48.99	177.6	59.6%	n/a	Pharmaceuticals & Biotech
AMR	US$192.52	-8.0%	62.2%	US$2.5b	US$201.00	1.2	59.6%	0%	Materials
HUMA	US$0.65	0.5%	-57.8%	US$143.3m	US$5.10	70.3	59.5%	n/a	Pharmaceuticals & Biotech
ZENA	US$2.17	-3.1%	-8.1%	US$122.6m	US$6.99	20.2	59.5%	n/a	Software
SWBI	US$14.34	-3.5%	56.9%	US$638.0m	US$15.00	58.6	59.3%	3.6%	Consumer Durables
REKR	US$0.76	0.2%	-0.7%	US$103.6m	US$3.00	2.1	59.3%	n/a	Software
TVGN	US$5.73	28.5%	-89.4%	US$23.9m	n/a	-0.9	59.3%	n/a	Pharmaceuticals & Biotech
VRDN	US$14.95	-20.6%	24.4%	US$1.5b	US$35.00	21.6	59.3%	n/a	Pharmaceuticals & Biotech
IVVD	US$1.76	37.5%	220.6%	US$497.7m	US$10.00	9.3	59.3%	n/a	Pharmaceuticals & Biotech
ACVA	US$4.33	-0.7%	-69.7%	US$753.7m	US$9.12	1.8	59.2%	n/a	Commercial Services
VERX	US$10.80	-10.2%	-71.9%	US$1.7b	US$19.14	238.8	59.2%	n/a	Software

Page 29 of 215